Integra Lifesciences Holdings Corp
NASDAQ:IART
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
11.05
26.55
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Integra Lifesciences Holdings Corp
EPS (Diluted)
Integra Lifesciences Holdings Corp
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Integra Lifesciences Holdings Corp
NASDAQ:IART
|
EPS (Diluted)
-$6
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-91%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
EPS (Diluted)
$5
|
CAGR 3-Years
0%
|
CAGR 5-Years
17%
|
CAGR 10-Years
6%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
EPS (Diluted)
$1
|
CAGR 3-Years
64%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
EPS (Diluted)
$7
|
CAGR 3-Years
6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
EPS (Diluted)
$8
|
CAGR 3-Years
21%
|
CAGR 5-Years
34%
|
CAGR 10-Years
10%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
EPS (Diluted)
$7
|
CAGR 3-Years
26%
|
CAGR 5-Years
21%
|
CAGR 10-Years
17%
|
|
Integra Lifesciences Holdings Corp
Glance View
Integra LifeSciences Holdings Corp., an influential player in the medical technology landscape, traces its origins back to a vision of creating life-enhancing innovations for surgical procedures. Founded in the late 1980s, Integra has evolved into a formidable presence, driven by a commitment to delivering solutions that improve patient outcomes in regenerative medicine and surgical care. The company operates primarily through two segments: the Codman Specialty Surgical and the Tissue Technologies segment. By focusing on these two areas, Integra leverages its expertise in surgical tools, neurocritical care, and advanced wound care, appealing to healthcare professionals worldwide. This strategic segmentation enables the company to cater to a diverse clientele, encompassing hospitals and other medical institutions in North America, Europe, and internationally. Integra's revenue streams are notably derived from the design, manufacture, and distribution of a comprehensive suite of products used in neurosurgery, acute wound care, and reconstructive surgery. The company's innovative products, including precision surgical instruments and biologics that promote regenerative tissue healing, are key contributors to its financial success. By continuously investing in research and development, Integra ensures the introduction of cutting-edge solutions that address the evolving needs of the healthcare industry. The company's growth strategy hinges on both organic innovation and strategic acquisitions, fostering an environment where technological advancements seamlessly integrate with expanding market reach. This symbiotic approach not only solidifies Integra's position in the med-tech arena but also underpins its growth potential in an ever-competitive healthcare sector.
See Also
What is Integra Lifesciences Holdings Corp's EPS (Diluted)?
EPS (Diluted)
-6.5
USD
Based on the financial report for Sep 30, 2025, Integra Lifesciences Holdings Corp's EPS (Diluted) amounts to -6.5 USD.
What is Integra Lifesciences Holdings Corp's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-91%
Over the last year, the EPS (Diluted) growth was -7 078%.